Trial Profile
Efficacy and safety in adequate regimen of aflibercept therapy for patients with diabetic macular edema
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 24 May 2016 New trial record